Mouse neuronal nitric-oxide synthase 2 (nNOS2) is a unique natural variant of constitutive neuronal nitricoxide synthase (nNOS) specifically expressed in the central nervous system having a 105-amino acid deletion in the heme-binding domain as a result of in-frame mutation by specific alternative splicing. The mouse nNOS2 cDNA gene was heterologously expressed in Escherichia coli, and the resultant product was characterized spectroscopically in detail. Purified recombinant nNOS2 contained heme but showed no L-arginine-and NADPHdependent citrulline-forming activity in the presence of Ca 2Ű -promoted calmodulin, elicited a sharp electron paramagnetic resonance (EPR) signal at g â«Ű⏠6.0 indicating the presence of a high spin ferriheme as isolated and showed a peak at around 420 nm in the CO difference spectrum, instead of a 443-nm peak detected with the recombinant wild-type nNOS1 enzyme. Thus, although the heme domain of nNOS2 is capable of binding heme, the heme coordination geometry is highly abnormal in that it probably has a proximal non-cysteine thiolate ligand both in the ferric and ferrous states. Moreover, negligible spectral perturbation of the nNOS2 ferriheme was detected upon addition of either L-arginine or imidazole. These provide a possible rational explanation for the inability of nNOS2 to catalyze the cytochrome P450-type monooxygenase reaction.
Nitric-oxide synthase (NOS)1 is a complex flavo-hemoprotein that catalyzes the conversion of L-arginine to citrulline in the presence of molecular oxygen, NADPH, tetrahydrobiopterin (H 4 BP), and Ca 2Ï© -promoted calmodulin with concomitant production of nitric oxide (NO) (1-8). It is a bifunctional enzyme that is comprised of an N-terminal heme-binding domain and the C-terminal flavin-containing cytochrome P450 reductaselike domain. Ca 2Ï© -promoted calmodulin binding activates electron transfer from the flavin site to the heme site (9), where NO is produced at the heme center in the presence of oxygen, H 4 BP, and L-arginine (6,8). The heme-binding domain of NOS shows negligible structural homology to regular cytochrome P450 (6,8,10,11), although a wide range of spectroscopic evidence supports coordination of an endogenous thiolate sulfur donor ligand to the central heme iron (12-15). Recent high resolution x-ray crystal structure determinations of the monomeric and dimeric forms of the heme-binding domain fragment of inducible NOS (iNOS) have proven that the overall protein topology is very different from that of either regular cytochrome P450 or chloroperoxidase, although the proximal ligand to the central ferriheme iron is a conserved cysteine residue (10, 11). The endogenous thiolate sulfur donor ligand to the central heme iron provides a rational basis for the proposed two-step sequential catalytic mechanism of NOS, where the first step involving the formation of the intermediate N -hydroxyarginine may follow a cytochrome P450-type monooxygenase mechanism (1, 16 -20). The substrate (L-arginine) and pterin cofactor (H 4 BP) binding sites have been defin...